Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study
about
Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolatesA Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-AnalysisIntegration of published information into a resistance-associated mutation database for Mycobacterium tuberculosisMDR-TB Outbreak among HIV-Negative Tunisian Patients followed during 11 YearsComparison and development of pyrazinamide susceptibility testing methods for tuberculosis in Thailand.Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strainA joint cross-border investigation of a cluster of multidrug-resistant tuberculosis in Austria, Romania and Germany in 2014 using classic, genotyping and whole genome sequencing methods: lessons learnt.A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis.Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in GeorgiaIn Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1.Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, ChinaHost-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives.The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity?Epidemiologic Correlates of Pyrazinamide-Resistant Mycobacterium tuberculosis in New York City.Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study.Mycobacterium tuberculosis pncA Polymorphisms That Do Not Confer Pyrazinamide Resistance at a Breakpoint Concentration of 100 Micrograms per Milliliter in MGIT.Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates.Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of CaseumPyrazinamide Is Active against Mycobacterium tuberculosis Cultures at Neutral pH and Low Temperature.Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosisWhole-genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates from MyanmarPopulation-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia.Pyrazinamide: the importance of uncovering the mechanisms of action in mycobacteria.Fighting an old disease with modern tools: characteristics and molecular detection methods of drug-resistant Mycobacterium tuberculosis.Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools.Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in ChinaImproved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide Resistance.Real-Time Sequencing of Mycobacterium tuberculosis: Are We There Yet?Genome sequencing reveals novel deletions associated with secondary resistance to pyrazinamide in MDR Mycobacterium tuberculosis.A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide.Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates.Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey.
P2860
Q27004697-0B16F653-DE4C-4EED-B77D-0CE093F64365Q27011264-87DEBB27-434A-4669-AAB2-ED2FADCE8769Q28087770-242BCEDC-4F81-44B3-81AA-7CA38AD1E3E5Q28551671-C19B57DD-C596-49B1-B973-AF6BA1703F17Q30278824-961FD079-D584-4AFF-80CC-B70056F749A4Q30374556-5E4E9BC8-6779-4B60-8EA6-800F763623DEQ33601686-7895B8FC-41E5-43B2-ACCB-EFC6D16A19E4Q33812455-CD359C3B-99D6-4ED6-A00E-8AEA49181433Q33896434-07F96085-EADD-426F-968D-02E7E5C245BCQ33912749-615CE300-CBAD-44CD-92EE-9F57C0E970F8Q35076847-119CA8CB-C641-4069-8D6F-FD5F5A792B36Q35743972-F5D390A7-11AD-487D-ACE5-542EE838B95FQ36019139-AD83B396-C61D-448E-A50D-1DC6CCC82FD2Q36076037-DAC3AF7C-C98C-44E1-B948-52D3C5DB9D29Q36084640-65F4AA87-219B-4F31-9987-EBF731D7B0E2Q36174022-0CCC9718-5E69-40FA-BC07-CCFBC04792A9Q36297624-540FC4D8-8344-49D6-8FF0-48BB8F480CFFQ36571981-FCDADA02-B4F7-4EB0-AD6E-37AE87534DFBQ37120038-96AEC3D2-4EA0-4E65-B68D-DA62B8115060Q37133281-F39884A7-4648-4E3A-982C-A12B7B61A439Q37229528-5DF68731-7D1A-48F8-968A-DCD8DA4C64C9Q37270722-21CA33D4-4F5C-4A87-92BF-8916A6F3C687Q37358689-886AD1F2-EC83-4CD1-BCF8-9732B308362CQ37739640-934DFC8A-F854-473B-AD36-B6A8805DD144Q38368943-C5F0DAAA-9B54-4E19-AC4B-E4469049E62FQ38545953-A2D5A9D7-9F08-4C06-AF2B-03BBD8E9068EQ38674445-5F2A20C9-D2C4-4891-B2C9-F2AD0FF7CBDDQ38739933-FFFDA247-EC86-4F79-B8BC-56DA17DCCF4AQ38829192-2ED69EBC-CAD8-476C-A139-34E7F1302730Q39785436-546BECA4-7048-40AF-8FC2-086C46CC3F91Q40048055-901F44ED-5FF9-4CA8-ACB9-63C1141A3CF4Q40290488-B2A48774-CF47-4CDE-9229-44C42964D122Q40936781-82859902-78BF-4DA6-8E14-825D9DC2D454Q41701192-A4805F07-6D70-4CB2-9BA5-7917D9F5A07DQ42278779-C4AB0093-170A-4D52-9EDC-68FB88438DC0Q42618592-DFA74D42-7085-4B46-8995-2F70B6F5DA03Q43923911-46339BD2-1698-41B0-BAFA-6CA7D44AF265Q45223094-640A987C-F6B7-431C-A007-04207D882CF3Q46319545-180D86E0-CFE8-4776-BB09-0247EAFA561AQ46683653-9D3A352A-EAFE-4F45-93C0-55C749EE7036
P2860
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study
@ast
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study
@en
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study
@nl
type
label
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study
@ast
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study
@en
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study
@nl
prefLabel
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study
@ast
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study
@en
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study
@nl
P2093
P2860
P50
P356
P1433
P1476
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study
@en
P2093
Daiva Bakonyte
Daniela M Cirillo
Edita Pimkina
Jim Werngren
Mikael Mansjö
Nicola Casali
Petras Stakenas
Sabine Rüsch-Gerdes
Silke Feuerriegel
Stefan Niemann
P2860
P304
P356
10.1128/MBIO.01819-14
P50
P577
2014-10-21T00:00:00Z